Join the DDA or

Government and industry get round table of branded drugs pricing

New scheme to start in 2024

May 5th 2023

Tagged: political news

By Ailsa Colquhoun

Negotiations for the successor to the voluntary scheme for branded medicines, pricing and access (VPAS) have begun between the government, NHS England and the pharmaceutical industry.

The current scheme – which came into force in 2019 – is due to expire at the end of 2023. Negotiations are due to conclude in the autumn ahead of the new scheme starting on 1 January 2024.

The aim of the scheme is to agree a system of NHS branded medicine pricing that supports drug innovation, NHS financial sustainability and patient outcomes.